Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02205931Phase 4Unknown
Phase 4, randomised, open-label trial in epilepsy (2 arms), sponsored by University College London. Primary endpoint: Number of seizures. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02205931.